Figure 3
From: MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma
Kaplan-Meier cumulative survival (months) in glioblastoma patients plotted according to concomitant gene methylation patterns. (A) MGMT and GATA6 gene methylation status (log-rank test, χ 2 = 13.058, df = 3, P = 0.005), (B) MGMT and CASP8 gene methylation status (log-rank test, χ 2 = 12.314, df = 3, P = 0.006), (C) GATA6 and CASP8 gene methylation status (log-rank test, χ 2 = 7.712, df = 3, P = 0.052).